Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies - PubMed
4 hours ago
- #diabetic macular edema
- #pharmacological treatment
- #precision medicine
- DME management is shifting from high-frequency anti-VEGF monotherapy to durable, multi-mechanism strategies.
- New approaches target pathways beyond VEGF, such as angiopoietin-2, plasma kallikrein-kinin system, and tyrosine kinase signaling.
- Future DME treatment aims for injection-sparing, personalized precision medicine focusing on long-term durability and functional outcomes.